Philanthropy and trusts

Individual philanthropists and grant-making trusts and foundations play a pivotal role in funding our vital work.

We need your generous support so that we can continue to fight pancreatic cancer on all fronts; through investing in cutting-edge research, providing specialist support and information, and campaigning for change.

Get in touch

If you’re considering a gift of £5,000 or more, thank you. You’ll be joining a dedicated community helping to transform the future for people affected by pancreatic cancer.

Our dedicated philanthropy team will work closely with you to ensure your gift reflects what matters most to you, from funding bold new research and speeding up diagnosis to supporting patients and families with expert care and information. You’ll receive personalised updates on the impact of your support, and opportunities to connect more deeply with the work you’re helping to make possible.

To find out more about making a major gift, please contact:

Sabina Pasokhy
Philanthropy Lead 
Email: Sabina.Pasokhy@pancreaticcancer.org.uk

What do we mean by a significant gift?

At Pancreatic Cancer UK we are extremely grateful for each and every donation we receive. We define donations of over £5,000 as a significant gift.

Make us your beneficiary charity of choice

If you’re holding an event and would like to support a charity, we would love to work with you to make your event as special as possible. 

Find out more
  • New combination of drugs shown to effectively treat pancreatic cancer in mice

    New combination of drugs shown to effectively treat pancreatic cancer in mice

    Our Head of Research, Dr Madina Kara, comments on the recent news that scientists from the Spanish National Research Centre have been able to eliminat...

  • Our response to the National Cancer Plan for England

    Our response to the National Cancer Plan for England

    Today, Secretary of State for Health and Social Care, Wes Streeting revealed the eagerly awaited National Cancer Plan for England. Our CEO, Diana Jupp...

  • Rare Cancers Bill passes Second Reading

    Rare Cancers Bill passes Second Reading

    Earlier this month – fittingly, during Less Survivable Cancers Week – our team were delighted to be in the House of Lords to watch the Rare Cancers Bi...